Orphan drugs amendments
Executive SummarySen. Hatch (R-Utah) introduced bill May 13 which would allow patentable products to receive seven years of exclusivity under the Orphan Drug Act. The measure is similar to a bill recently introduced in the House by Rep. Waxman (D-Calif.) ("The Pink Sheet" May 6, T&G-91.
You may also be interested in...
Quanta Dialysis is linking up with B. Braun Avitum UK to support patients with Quanta’s personal hemodialysis device in the home. See what Quanta CEO John Milad said about it here.
Cosmetics Europe’s Director-General John Chave discusses next steps in the European Union’s proposed drive to ban manufactured microplastic in all cosmetic products. Industry continues to fight for something more proportionate, but it’s up against powerful forces in today’s European theater.
HanAll and Daewoong remain upbeat on dry eye candidate HL036 and are gearing up for a second Phase III US study despite the first missing its primary endpoint in just-released top-line results.